| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2afec86507fc41d4fd24a6693763f876 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
| filingDate |
2015-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5aa3d916f579a8a5f174a197b67dc3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0085064fbd5f8cbc2fef18f375091b7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b505dafe42f1382178e27e222e3f973
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b82d3de1fbab6050c24f149f47c97ebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b1e32d2504138d16f00491812d3b914 |
| publicationDate |
2016-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2016050202-A |
| titleOfInvention |
Antistress or homeostasis composition containing lactobionic acid |
| abstract |
Disclosed is a composition for preventing or alleviating symptoms caused by excessive secretion of cortisol induced by stress. A composition for anti-stress or homeostasis comprising lactobionic acid or a salt of lactobionic acid as an active ingredient. A composition that has an effect of preventing or alleviating symptoms caused by stress-induced excessive secretion of cortisol and preventing or alleviating stress-induced inflammatory reactions. The technique uses a composition for preventing or alleviating stress-induced anxiety disorders. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7228531-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020519649-A |
| priorityDate |
2014-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |